Your browser doesn't support javascript.
loading
Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome.
Richardson, Paul G; Triplett, Brandon M; Ho, Vincent T; Chao, Nelson; Dignan, Fiona L; Maglio, Michelle; Mohty, Mohamad.
Afiliação
  • Richardson PG; a Hematologic Oncology , Harvard Medical School, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute , Boston , MA , USA.
  • Triplett BM; b Hematopoietic Stem Cell Transplantation Program , Dana-Farber Cancer Institute , Boston , MA , USA.
  • Ho VT; c Bone Marrow Transplantation and Cellular Therapy , St. Jude Children's Research Hospital , Memphis , TN , USA.
  • Chao N; b Hematopoietic Stem Cell Transplantation Program , Dana-Farber Cancer Institute , Boston , MA , USA.
  • Dignan FL; d Division of Hematologic Malignancies and Cellular Therapy , Duke Cancer Institute, Duke University , Durham , NC , USA.
  • Maglio M; e Department of Clinical Haematology , Central Manchester NHS Foundation Trust , Manchester , UK.
  • Mohty M; a Hematologic Oncology , Harvard Medical School, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute , Boston , MA , USA.
Expert Rev Clin Pharmacol ; 11(2): 113-124, 2018 Feb.
Article em En | MEDLINE | ID: mdl-29301447

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polidesoxirribonucleotídeos / Hepatopatia Veno-Oclusiva / Fibrinolíticos Tipo de estudo: Clinical_trials / Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polidesoxirribonucleotídeos / Hepatopatia Veno-Oclusiva / Fibrinolíticos Tipo de estudo: Clinical_trials / Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article